Trillium Therapeutics Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 33

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 10

  • Investments
  • 3

Trillium Therapeutics General Information

Description

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2488 Dunwin Drive
  • Mississauga, Ontario L5L 1J9
  • Canada
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Former Stock Listing
TRIL
Corporate Office
  • 2488 Dunwin Drive
  • Mississauga, Ontario L5L 1J9
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Trillium Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Trillium Therapeutics‘s full profile, request access.

Request a free trial

Trillium Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the tr
Drug Discovery
Mississauga, Canada
33 As of 2020

Princeton, NJ
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Trillium Therapeutics Competitors (14)

One of Trillium Therapeutics’s 14 competitors is Bristol-Myers Squibb, a Corporation company based in Princeton, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bristol-Myers Squibb Corporation Princeton, NJ
AstraZeneca Formerly PE-Backed Cambridge, United Kingdom
EMD Serono Corporation Boston, MA
OnKure Therapeutics Formerly VC-backed Boulder, CO
Biogen Formerly VC-backed Cambridge, MA
You’re viewing 5 of 14 competitors. Get the full list »

Trillium Therapeutics Patents

Trillium Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2018527856-A Computer-implemented encryption method for improving computer network, terminal, system and computer-readable medium for them Active 18-Sep-2015
JP-6495548-B2 Computer-implemented encryption method for improving computer network, terminal, system and computer-readable medium for them Inactive 18-Sep-2015

Trillium Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Trillium Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Trillium Therapeutics‘s full profile, request access.

Request a free trial

Trillium Therapeutics Acquisitions (3)

Trillium Therapeutics’s most recent deal was a Merger/Acquisition with Fluorinov Pharma for . The deal was made on 27-Jan-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Fluorinov Pharma 27-Jan-2016 Merger/Acquisition Drug Discovery
Trillium Therapeutics (acquired 2013) 09-Apr-2013 Merger/Acquisition Biotechnology
Stem Cell Therapeutics 12-Feb-2013 Merger/Acquisition Biotechnology
To view Trillium Therapeutics’s complete acquisitions history, request access »

Trillium Therapeutics FAQs

  • When was Trillium Therapeutics founded?

    Trillium Therapeutics was founded in 2004.

  • Where is Trillium Therapeutics headquartered?

    Trillium Therapeutics is headquartered in Mississauga, Canada.

  • What is the size of Trillium Therapeutics?

    Trillium Therapeutics has 33 total employees.

  • What industry is Trillium Therapeutics in?

    Trillium Therapeutics’s primary industry is Drug Discovery.

  • Is Trillium Therapeutics a private or public company?

    Trillium Therapeutics is a Private company.

  • What is the current valuation of Trillium Therapeutics?

    The current valuation of Trillium Therapeutics is .

  • What is Trillium Therapeutics’s current revenue?

    The current revenue for Trillium Therapeutics is .

  • How much funding has Trillium Therapeutics raised over time?

    Trillium Therapeutics has raised $223M.

  • Who are Trillium Therapeutics’s investors?

    Deerfield Management, Frazier Healthcare Partners, HSMR Advisors, New Enterprise Associates, and Nexus Life Science Partners are 5 of 11 investors who have invested in Trillium Therapeutics.

  • Who are Trillium Therapeutics’s competitors?

    Bristol-Myers Squibb, AstraZeneca, EMD Serono, OnKure Therapeutics, and Biogen are some of the 14 competitors of Trillium Therapeutics.

  • When was Trillium Therapeutics acquired?

    Trillium Therapeutics was acquired on 17-Nov-2021.

  • Who acquired Trillium Therapeutics?

    Trillium Therapeutics was acquired by Pfizer.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process